Cite
HARVARD Citation
Gaertner, S. et al. (2017). Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes. International journal of cardiology. pp. 103-109. [Online].